Management of the Pt with an Incidentally Discovered Adrenal Mass - Flowchart
Management of the Pt with an Incidentally Discovered Adrenal Mass - Flowchart
«Flowchart»

ALGORITHM FOR THE MANAGEMENT OF THE PT WITH AN INCIDENTALLY DISCOVERED ADRENAL MASS

ALGORITHM FOR THE MANAGEMENT OF THE PT WITH AN INCIDENTALLY DISCOVERED ADRENAL MASS

ALGORITHM FOR THE MANAGEMENT OF THE PT WITH AN INCIDENTALLY DISCOVERED ADRENAL MASS

ALGORITHM FOR THE MANAGEMENT OF THE PT WITH AN INCIDENTALLY DISCOVERED ADRENAL MASS

Repeat imaging as needed

Repeat imaging as needed

Repeat imaging as needed

CT/MRI finding of incidentally discovered adrenal mass

CT/MRI finding of incidentally discovered adrenal mass

CT/MRI finding of incidentally discovered adrenal mass

CT/MRI finding of incidentally discovered adrenal mass

Unilateral adrenalectomy

Unilateral adrenalectomy

Unilateral adrenalectomy

F/U as needed

F/U as needed

F/U as needed

Repeat screening for hormone excess after 12 months

Repeat screening for hormone excess after 12 months

Repeat screening for hormone excess after 12 months

Neg.

Neg.

Neg.

Pos.

Pos.

Pos.

End

End

End

Confirmatory testing

Confirmatory testing

Confirmatory testing

Neg.

Neg.

Neg.

Unilateral adrenalectomy

Unilateral adrenalectomy

Unilateral adrenalectomy

CT, computed tomography; F/U, follow-up; MRI, magnetic resonance imaging.

CT, computed tomography; F/U, follow-up; MRI, magnetic resonance imaging.

CT, computed tomography; F/U, follow-up; MRI, magnetic resonance imaging.

Screening for hormone excess


Plasma metanephrines or 24-h urine for metanephrine/catecholamine excretion
24-h urine for free cortisol excretion, plasma ACTH, midnight plasma (or salivary) cortisol, dexamethasone 1 mg overnight test (perform at least two out of four tests)
Plasma aldosterone and plasma renin in pts with hypertension and/or hypokalemia
If tumor >4 cm: Serum 17-hydroxyprogesterone and DHEAS

Screening for hormone excess


Plasma metanephrines or 24-h urine for metanephrine/catecholamine excretion
24-h urine for free cortisol excretion, plasma ACTH, midnight plasma (or salivary) cortisol, dexamethasone 1 mg overnight test (perform at least two out of four tests)
Plasma aldosterone and plasma renin in pts with hypertension and/or hypokalemia
If tumor >4 cm: Serum 17-hydroxyprogesterone and DHEAS

Screening for hormone excess

Screening for hormone excess


Plasma metanephrines or 24-h urine for metanephrine/catecholamine excretion
24-h urine for free cortisol excretion, plasma ACTH, midnight plasma (or salivary) cortisol, dexamethasone 1 mg overnight test (perform at least two out of four tests)
Plasma aldosterone and plasma renin in pts with hypertension and/or hypokalemia
If tumor >4 cm: Serum 17-hydroxyprogesterone and DHEAS


Plasma metanephrines or 24-h urine for metanephrine/catecholamine excretion
24-h urine for free cortisol excretion, plasma ACTH, midnight plasma (or salivary) cortisol, dexamethasone 1 mg overnight test (perform at least two out of four tests)
Plasma aldosterone and plasma renin in pts with hypertension and/or hypokalemia
If tumor >4 cm: Serum 17-hydroxyprogesterone and DHEAS

Positive

Positive

Positive

Negative but imaging suggestive of malignancy:


Size >4 cm
High CT density (>20 HU)

Negative but imaging suggestive of malignancy:


Size >4 cm
High CT density (>20 HU)


Size >4 cm
High CT density (>20 HU) Negative but imaging suggestive of malignancy

Negative and imaging not suggestive of malignancy:


Size <4 cm
Low CT density (<10 HU)

Negative and imaging not suggestive of malignancy:

and not


Size <4 cm
Low CT density (<10 HU)


Size <4 cm
Low CT density (<10 HU) Negative and imaging not suggestive of malignancy

No further evaluation

No further evaluation

No further evaluation